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Prostaglandin H synthases (PGHSs) are N-glycosylated membrane proteins that catalyse the committed step in
prostaglandin synthesis. Unlike PGHS-2, the production of recombinant PGHS-1 in non-mammalian expression
systems is complicated. The majority of the heterologous enzyme is inactive due to misfolding. Correct N-glycosylation
is proposed to be obligatory for proper folding of mammalian PGHSs. In this study, human PGHS-1 and -2 (hPGHS-1
and -2) were expressed in the yeast Pichia pastoris. Recombinant hPGHS-2 was catalytically active, whereas hPGHS-1
was inactive. Accumulation of non-glycosylated hPGHSs was not observed in the crude lysate of the yeast cells.
The N-glycosylation patterns of the purified recombinant proteins were characterised using nano-LC/MS/MS.
The isoforms exhibited similar N-glycosylation site occupancy. The results indicate that there are more complex
grounds for the inactivity of the recombinant hPGHS-1 produced in yeast.
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Prostaglandin H synthases (PGHSs, also known as cycloox-
ygenases or prostaglandin-endoperoxide synthases) are di-
meric membrane proteins that catalyse the bis-oxidation of
arachidonic acid (AA) to prostaglandin G2 (PGG2) and the
subsequent reduction of PGG2 to PGH2. The downstream
prostanoids play basic housekeeping as well as several
pathophysiological roles in the body. Non-steroidal anti-
inflammatory drugs inhibit the bis-oxidation reaction of
PGHSs, thus blocking the key step in prostanoid synthesis.
Vertebrates have two distinct PGHS isoforms: PGHS-1
and -2 (Kulmacz et al. 2003; Rouzer and Marnett 2009;
Simmons et al. 2004; Smith et al. 2000b). The majority of
the studies associated with mammalian PGHSs have been
conducted with native or recombinant ovine PGHS-1 and
recombinant human or murine PGHS-2 (Mbonye et al.
2006; Musee and Marnett 2012; Nemeth et al. 2001;
Vecchio and Malkowski 2011; Vecchio et al. 2012). Thus
there is little experimental data on human PGHSs* Correspondence: nigulas.samel@ttu.ee
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in any medium, provided the original work is p(hPGHSs), particularly concerning hPGHS-1. Although
the amino acid sequences of PGHS-1 and PGHS-2 are
about 60% identical, unlike PGHS-2, the production of
recombinant PGHS-1 in insect cells is obstructed as
most of the enzyme is inactive and likely misfolded
due to deficient glycosylation (Kulmacz et al. 2003;
Shimokawa and Smith 1992). There are four and five
N-glycosylation recognition sequons (N-X-S/T, X ≠ P)
in the primary structures of hPGHS-1 and hPGHS-2,
respectively (Figure 1A). N67, N143 and N409 (hPGHS-1
numbering) have been shown to be occupied in both iso-
forms and an additional site, N580 (human PGHS-2 num-
bering), in hPGHS-2 (Otto et al. 1993). The results of
several studies indicate that N-glycosylation of these sites
(except N580) is necessary for correct protein folding and/
or oligomerisation (Otto et al. 1993; O’Neill et al. 1994).
The glycosylation sites of murine PGHS-2 expressed in
insect cells have been characterised showing that N53
and N130 (corresponding to N67 and N143 in hPGHS-1)
are close to 100% glycosylated and that N396 (N409 in
hPGHS-1) and N580 are partially glycosylated (Nemeth
et al. 2001). hPGHSs contain 5 disulphide bonds, three
of which are located in the epidermal growth factorOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Construction, N-glycosylation and expression of hPGHSs. A, the positions of the N-glycosylation sites of the chimera and hPGHS
isoforms. The dashed lines connect N-glycosylation sites that are conserved between isoforms. Asparagines, which are not glycosylated in native
hPGHSs, are depicted with grey characters. N580 is designated by dark grey characters as about 50% of the native PGHS-2 is not glycosylated at
this site. The transition from hPGHS-2 to hPGHS-1 to form the chimera is shown as well. B, Western blot analyses of the microsomes of P. pastoris
cells expressing the non-optimised hPGHS-1 (1) and the codon optimised hPGHS-1 (2). hPGHS-1 was expressed with the native signal sequence
and the optimised sequence contained an affinity tag. C, Western blot analysis of the purified hPGHSs subjected to N-glycosylation analysis:
hPGHS-1 (lane 1), chimera (lane 2) and hPGHS-2 (lane 3). The calculated molecular weights of the non-glycosylated proteins were 67.2, 66.3 and
68.8 kDa, respectively, assuming that the signal peptide was cleaved and taking into account the double STEL and polyhistidine tag.
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insertion in the N-terminal part of hPGHS-1 preceding
the disulphide rich region (Kulmacz et al. 2003; Simmons
et al. 2004). An ovine PGHS-1 mutant that had a dis-
rupted disulphide bond (C59-C69) lacked activity, thus
affirming the importance of an intact EGF-like domain for
proper folding (Smith et al. 2000b).
The N-glycosylation pattern is highly variable among
non-mammalian PGHSs. The primary structures of
the red algal PGHSs from Gracilaria vermiculophylla
(G. vermiculophylla) and Coccotylus truncatus con-
tain two and three, the coral PGHS-A and PGHS-B
from Gersemia fruticosa four and six, the coral PGHS
from Plexaura homomalla three and the amphipod
PGHSs from Gammarus and Caprella four and three
N-glycosylation sequons, respectively (Järving et al.
2004; Valmsen et al. 2001; Varvas et al. 2009, 2013).
Unlike animal PGHSs, the G. vermiculophylla PGHS
does not require N-glycosylation for proper folding
and expresses easily as a fully functional enzyme in
Escherichia coli (E. coli) (Varvas et al. 2013). However,
the expression of functional mammalian PGHSs requires
the employment of a eukaryotic expression system. The
yeast Pichia pastoris (P. pastoris) is capable of performing
eukaryotic posttranslational modifications and therefore
can be exploited for the production of recombinant mam-
malian glycoproteins (Macauley-Patrick et al. 2005). Re-
cently, we used P. pastoris for heterologous expression of
catalytically active hPGHS-2 (Kukk et al. 2012). hPGHS-1expressed in similar conditions was inactive and solubilised
poorly (personal data). The insufficient N-glycosylation of
PGHS-1 in insect cells (Kulmacz et al. 2003; Shimokawa
and Smith 1992) has led to the need for the characterisa-
tion of the N-glycosylation sites of hPGHS-1 produced in
P. pastoris.
Mass-spectrometry based proteomics has become a stand-
ard method for the characterisation of post-translational
modifications, including protein N-glycosylation (Pan
et al. 2011). One way to map protein N-sites is to use a
highly specific enzyme, PNGase F, which selectively hy-
drolyses N-oligosaccharides from respective peptides,
thereby introducing specific mass-shifts. These shifts
can be readily detected and localized with modern high
resolution instruments. However, the reliability of such
mapping is impaired by spontaneous deamidation that
occurs in proteins and peptides under common alkaline
sample preparation conditions. Thus artificial deamidation
must be accounted for. An improved protocol was re-
cently introduced using acidic pH with heavy water for
the sample preparation of N-glycosylated proteins (Hao
et al. 2011).
The aim of the present study was to investigate the
N-glycosylation patterns of hPGHS-1 and hPGHS-2
produced in P. pastoris and verify whether insufficient
N-glycosylation causes the misfolding of recombinant
hPGHS-1. Therefore, hPGHS-1, hPGHS-2 and a chimera
consisting of the two isoforms were expressed in P. pastoris
and purified using Ni-affinity chromatography. The
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nano-LC/MS/MS based proteomics. The structural char-
acterisation of the oligosaccharides attached was not the
primary objective.
Results and discussion
Expression of the recombinant hPGHSs in P. pastoris
GS115
So far, functional mammalian PGHSs have been expressed
in the baculoviral system (Vecchio and Malkowski 2011;
Zou et al. 2012) and in mammalian cell lines (Mbonye
et al. 2006, 2008), and hPGHS-2 recently in the yeast
P. pastoris (Kukk et al. 2012). Here, the heterologous
expression of hPGHS-2 was carried out as described
by our group previously (Kukk et al. 2012), whereas
similar expression conditions were employed for all
the proteins subjected to study. The hPGHS-2 se-
quence contained a C-terminal polyhistidine tag and
the native signal sequence was replaced with P. pas-
toris acid phosphatase secretion signal. Despite having
a secretion signal, the protein was expressed intracellu-
larly. Our previous study demonstrated that hPGHS-2
is produced in the yeast as a functional protein inde-
pendent of the signal sequence (native or yeast) used
(Kukk et al. 2012).
According to published data, in order to produce equal
amounts of recombinant PGHS isoforms in the baculo-
viral expression system the heterologous expression of
PGHS-1 requires extended expression time and scaling up
of the insect cell culture volume approximately three
times (Smith et al. 2000a). Similarly, the production of
hPGHS-1 in P. pastoris proved complicated. At first, we
subjected native hPGHS-1 to heterologous expression;
however, the expression level of the protein was very low
(Figure 1B, lane 1). According to the Graphical Codon
Usage Analyser (http://gcua.schoedl.de), the codon usage
of hPGHS-1 is less compatible with the yeast P. pastoris
than that of hPGHS-2. Therefore, the codon usage was
adjusted. In addition, GC content was optimised, potential
mRNA instability elements were removed and yeast Kozak
consensus sequence (AAAAATGTC) was used to initiate
translation. The sequence encoding a polyhistidine tag
was inserted into the C-terminal end, and the four amino
acid residues preceding the tag (STEL) were repeated after
the tag (Figure 1A). The native sequence of hPGHS-1
contained an unwanted EcoR I restriction site that wasTable 1 hPGHSs subjected to N-glycosylation analysis
Recombinant vector Native/ optimised
optC-termHis6PGHS-1 pHIL-D2 Optimised
N-termPGHS-2/optC-termHis6 PGHS-1 pHIL-D2 Optimised, except t
C-termHis6PGHS-2-sp pHIL-S1 Native
1pmoles of prostaglandins formed in 10 min per 1 mg (wet weight) of yeast cells. Mremoved. The synthetic sequence has been submitted
to GenBank with the accession number KM112253.
The Western blot analysis of the microsomes of the re-
combinant P. pastoris cells revealed that the expression
level of the codon optimised hPGHS-1 was remarkably
higher (Figure 1B, lane 2). Nevertheless, the crude cell
preparation did not exhibit detectable cyclooxygenase
activity (Table 1). In addition, the poor solubilisation
of hPGHS-1 indicated that the protein was mostly
misfolded.
Conservation of the amino acid sequence between
PGHS-1 and -2 in the membrane binding domain
(MBD) is about half of overall protein identity (33%
versus 60%). In addition, the length of the N-terminal
signal peptide is remarkably different – 17 and 23 amino
acids in PGHS-1 and -2, respectively (Kulmacz et al.
2003). As hPGHS-1 expressed as an inactive protein, the
region of hPGHS-1 that has low amino acid sequence
similarity with hPGHS-2 was replaced with the respective
sequence of hPGHS-2. More precisely, an N-termPGHS-
2/optC-termHis6 PGHS-1 chimera was created that con-
sisted of the N-terminal part of hPGHS-2, including
the first three helices of MBD and the C-terminus of
hPGHS-1 (Figure 1A), whereas the hPGHS-1 sequence
was optimised for the yeast. The fourth helix of MBD
merges into the catalytic domain (Smith et al. 2000b)
and was, therefore, left unaltered. The recombinant
chimeric protein exhibited better solubilisation charac-
teristics compared to hPGHS-1 and exhibited detectable
catalytic activity. The characteristics of the hPGHSs sub-
jected to N-glycosylation analysis are presented in Table 1.
N-glycosylation analyses
The results of the analysis are summarised in Table 2.
Depending whether the asparagine residues were unmodi-
fied or deamidated by H2
16O or H2
18O it was possible to dis-
criminate between non-glycosylated (unmodified and 16O
deamidated) and glycosylated (18O deamidated) sites. Ex-
ample MS/MS spectra are presented in Figure 2 of a glyco-
sylation motif containing peptide in which variable site
occupancy can be confidently deduced. Using the described
protocol we observed 79 MS/MS events regarding 18O dea-
midated peptides of PGHS proteins. All were found to con-
tain N-glycosylation sequons and 70 scans also precisely
localised the modification to the expected residue. Only one
peptide (YNYQQFIYNNSILLEHGITQFVESFTR; PGHS-2)sequence Signal sequence Activity1
Native 0
he sequence of PGHS-2 PGHS-2 215 ± 19
Yeast 577 ± 21
ean ± S.D. (n = 5).
Table 2 Mass-spectrometric analysis of the N-glycosylation patterns of hPGHS proteins
Protein Enzyme(s) used Glycosylation
site




hPGHS-1 AspN + trypsin + GluC N67 + + + VariableII-III / YesI
N1031 - + + No
N143 + - + VariableII-III / YesI
N409 - - - ND2
hPGHS-2/-1
chimera
AspN + trypsin N53 + + + NoII / YesI
N1031 - + + No
N143 + - - Yes
N409 + - - Yes
hPGHS-2 trypsin N53 + + + NoII-IV / YesI
N130 + + + VariableIII-IV / YesI-II
N396 + + + VariableIII-IV / YesI-II
N580 + - - Yes
N5921 - - + No
1N-glycosylation sequons not glycosylated in native hPGHS proteins.
2no data.
I-IVhPGHS glycoforms, whereas I marks the protein with the highest molecular weight. If not depicted, the glycosylation state of the sequon was the same among
all the glycoforms subjected to analysis.
18O deamidated   peptid e m/z = 627.945 z = 3 + M(obs ) = 1880.81 4 ΔM (obs. – theor.) = -0.1 ppm
16O deamidated   peptid e m/z = 940.412 z = 2 + M(obs ) = 1878.80 9 ΔM (obs. – theor.) = 0.5 ppm


























Figure 2 Example fragmentation spectra of a PGHS-1N-glycosylation site containing peptide TGFYGENCSTPEFLTR, indicating variable
glycosylation. High mass accuracy of precursor peptides combined with MS/MS fragment ions readily captures expected 16O/18O dependent
mass-shifts and confidently identifies that the site has variable glycosylation state in the recombinant protein. y-series fragment ions which
pinpoint the modification within the sequence are indicated with red arrows (note, that beyond y9-fragment the masses are shifted relative
to the unmodified fragments according to the incorporated oxygen atom).
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cation was not on an N-sequon asparagine, 6 were localized
to the expected residue and 6 were ambiguous between the
two consecutive asparagines contained in the sequon.
Therefore, we conclude that the N-mapping approach pro-
duced confident assignments with very low level of conflict-
ing data. The complete list of the identified peptides is
presented in Additional file 1: Table S1 and the respective
mass spectrometry proteomics data have been deposited to
the ProteomeXchange Consortium (http://proteomecentral.
proteomexchange.org) (Vizcaino et al. 2013) via the PRIDE
partner repository with the dataset identifier PXD000965.
The analysis of the two dominant glycoforms of hPGHS-
2 (Figure 1C, lane 3) revealed that alternative glycosylation
at N53 differentiated the glycoforms. Both glycosylated and
non-glycosylated peptides were observed for N130 and
N396 indicating variable N-glycosylation of the sites in
lower molecular weight glycoforms. The fourth glyco-
sylation sequon at N580 was glycosylated. Therefore,
N-glycosylation of PGHS-2 in yeast and insect cells
(Nemeth et al. 2001) differ from each other.
The two electrophoretic bands of N-termPGHS-2/optC-
termHis6 PGHS-1 chimera (Figure 1C, lane 2) were ana-
lysed separately. In accordance with the site occupancy of
hPGHS-2, the double band turned out to be the result of
alternative glycosylation at N53 (hPGHS-2 numbering). Al-
though N103 constitutes the N-glycosylation sequon the
site was not occupied in the recombinant chimera pro-
duced in P. pastoris. The next two N-glycosylation sites
were occupied. Thus approximately 50% of the protein was
properly glycosylated. It may be speculated that the exten-
sive rearrangement of the amino acid sequence of hPGHS-
1 to form the chimera caused the low protein activity.
The majority of hPGHS-1 remained in the microsome
fraction and was excluded from subsequent analysis. Ac-
cording to Western blot analyses of the solubilised protein
fraction and the remaining microsome, both hPGHS iso-
forms exhibited similar protein patterns. Specifically, both
fractions contained multiple glycoforms with a slight pref-
erence for the less N-glycosylated proteins for the micro-
some. In addition, there were no noticeable protein bands
corresponding to non-glycosylated hPGHSs, as was ex-
pected in terms of insufficient N-glycosylation. The puri-
fied hPGHS-1 appeared as a double electrophoretic band,
whereas the molecular weight difference between the gly-
coforms was less noticeable than in the case of hPGHS-2
and the chimera (Figure 1C). The peptides containing the
first three sequons were identified, whereas N103 was not
glycosylated and N67 and N143 were variably glycosyl-
ated. Taking into account the glycosylation of hPGHS-2
and the chimera, alternative glycosylation at N67 probably
differentiated the dominant glycoforms. The fourth site
was not identified. Nevertheless, the analysis of the
chimera clearly confirmed that the sequon was glycosylated.In addition, the electrophoretic mobility of the glycoforms
of hPGHS-1 and the chimera (Figure 1C, lanes 1 and 2) in-
dicated that three sequons were occupied in the highest
molecular weight protein. Specifically, the protein band of
the chimera with three oligosaccharides appeared lower
than the putative respective glycoform of hPGHS-1,
whereas the calculated molecular weights of the non-
glycosylated chimera and hPGHS-1 were 66.3 and 67.2 kDa,
respectively. Therefore, the N-glycosylation pattern of the
purified hPGHS isoforms was similar.
Unlike hPGHS-2, the purified hPGHS-1 was catalytic-
ally inactive. The crude lysate of the yeast cells expressing
the chimera exhibited detectable cyclooxygenase activity,
which may indicate that the cause of the inactivity of
hPGHS-1 lies in the N-terminal region of the protein. The
PGHS-1 specific 8 amino acid N-terminal insertion was
removed in the chimera. It may be that the insertion has a
detrimental effect on the disulphide formation in yeast. In-
complete disulphide formation in P. pastoris has been de-
scribed for Stereum purpureum endopolygalacturonase I
(Ogawa et al. 2009) and human consensus interferon-
alpha mutant (Wu et al. 2010). Unfortunately, the posi-
tions of the disulphide bonds of hPGHSs could not be
determined simply by mass spectrometry, as the cysteines
involved in bonding are very close together in the se-
quence. The known pattern of disulphides of mammalian
PGHSs has been established from the crystal structures
(Kulmacz et al. 2003). Partial reduction of disulphide
bonds has been described for the analysis of disulphide
rich proteins (Foley et al. 2008). However, optimising the
conditions for the partial reduction and alkylation requires
significant amounts of recombinant protein, which be-
comes an obstacle when studying a relatively challenging
membrane protein.
The less noticeable molecular weight difference be-
tween the dominant glycoforms of hPGHS-1 may result
from a shorter oligosaccharide. The transfer of com-
pletely assembled oligosaccharide to protein is favoured
(Aebi 2013). In yeast, however, if the complete oligosac-
charide is not available, incompletely assembled oligo-
saccharides are transferred (Helenius and Aebi 2004).
Under the conditions where the yeast cells are forced to
over-express an aggregation-prone protein there may
be a lack of enzymes performing the biosynthesis of
lipid-linked oligosaccharides. The increased stress is
also reflected in lower cell densities for cultures ex-
pressing the misfolded recombinant protein.
The partial occupancy of the first N-glycosylation site of
hPGHSs was rather surprising. The sequon might not have
been fully glycosylated because the cysteine at position +1
was involved in disulphide bonding, and disulphide bond
formation can compete with N-glycosylation (Allen et al.
1995; Daly and Hearn 2005). Over-expression of Leishmania
major STT3D, a subunit of the oligosaccharyltransferase
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promoter, improved the N-glycosylation site occupancy of
the recombinant antibodies to greater than 99% (Choi et al.
2012). Similar co-expression with hPGHSs might increase
the proportion of the fully N-glycosylated protein.
The non-occupancy of the N-glycosylation sequon at
N103 in hPGHS-1 has barely been discussed in relevant
papers. It has been reported that the replacement of
hydrophobic amino acids in membrane binding helices
B and C with smaller neutral or hydrophilic residues re-
sults in N-glycosylation at N103 (Spencer et al. 1999),
and the N103Q mutant of ovine PGHS-1 retains 45-50%
of both peroxidase and cyclooxygenase activities (Otto
et al. 1993). The analysis of the protein environment of
N-glycosylation sites revealed that the lowest incidence
of the occupied sequons was on helices and the highest
on flexible loops at or after points where the secondary
structure changes (Petrescu et al. 2004; Zielinska et al.
2012). The distance from a transmembrane domain may
also influence N-glycosylation (Nilsson and von Heijne
1993). In agreement with the data reported previously
on ovine PGHS-1 (Otto et al. 1993), our study demon-
strates that the sequon at N103 in recombinant hPGHS-
1 is not occupied. Although PGHS-1 does not contain
transmembrane helices but is rather a monotopic mem-
brane protein (Picot et al. 1994), the location of the
sequon at the C-terminal end of helix C in MBD may
hinder the N-glycosylation process of that sequon.
To date it is not established clearly why PGHS-1 is
produced predominantly in a misfolded state in non-
mammalian expression systems. The beginning of the N-
glycosylation process is similar in all eukaryotes. In the
mammalian Golgi apparatus, a series of trimming and
addition reactions are performed that generate high-
mannose (five to six mannose residues), and complex or
hybrid oligosaccharides. The secreted proteins of P. pastoris
typically have oligosaccharide chains that contain eight to
nine mannose residues (Cereghino and Cregg 2000;
Montesino et al. 1998). It has been proposed that the
longer chains may interfere with the folding or functio-
nality of a heterologous mammalian protein (Montesino
et al. 1998). OST is a heterooligomeric complex that
plays a central role in protein N-glycosylation. Mam-
malian OST contains components that are homologous
to the yeast OST. Nevertheless, there are components
unique to the mammalian complex (Aebi 2013; Helenius
and Aebi 2004; Mohorko et al. 2011). Therefore, it may
be speculated that the yeast OST complex is sufficient
for N-glycosylation of PGHS-2, whereas proper fold-
ing of PGHS-1 requires specific mammalian OST sub-
units not found in yeast. However, the data obtained
in our study indicate that the N-glycosylation site oc-
cupancy of the PGHS isoforms is rather similar. It is
tempting to speculate that the exact composition orlength of the oligosaccharide is critical for proper folding
of hPGHS-1. Insufficient or improper disulphide forma-
tion also cannot be ruled out.
Methods
Expression and purification of hPGHSs
The codon-optimised cDNA of hPGHS-1 (GenBank ac-
cession number KM112253) in the pMK-RQ-Bb vector
(GeneArt, Life Technologies) was amplified using E. coli
DH5α. The sequence encoding hPGHS-1 was ligated
into the yeast vector pHIL-D2 (Life Technologies) using
the EcoR I restriction site. N-termPGHS-2/optC-term-
His6 PGHS-1 fusion was achieved as follows: the N-
terminal part of hPGHS-2 (OriGene), including the first
three helices of the MBD, was amplified using the
primers hC2(EcoR I)up (5’ TTCGAATTCCGGATGCTC
GCCCGCGCCCTGCTGC 3’) and hC2(Hpa I)down
(5’ GAATGTTGTTAACAACGTTCCAAAATCC 3’);
the C-terminal part of the codon-optimised hPGHS-
1, starting with helix D, was amplified using opthC1
(Hpa I)up (5’ GGGAGTTCGTTAACGCTACTTTCA
TCAG 3’) and opthC1 C-termHis6(EcoR I)down (5’ G
CCGAATTCTTACAACTCAGTGGAGTGG 3’) (DNA
Technology). The PCR products were double digested
with Hpa I and EcoR I (Thermo Scientific) and ligated into
the EcoR I linearised pHIL-D2 vector. The recombinant
vector was amplified using E. coli DH5α and TOP10F’.
The correctness of the sequences was confirmed by
DNA sequencing (LGC). The recombinant expression
vectors were linearised with Pme I (Thermo Scientific)
and transformed into the P. pastoris strain GS115 (Life
Technologies) using the spheroplast method (Cregg
et al. 1985). The presence of the hPGHS-1 encoding se-
quences was confirmed by direct PCR of the P. pastoris
colonies, using the following upstream and downstream
primers: optQEV-up (5′ CCAGATGGCTGTTGGTCAA
GAGG 3′) and optTWG-down (5′ GGAACAACTGTT
CATCACCCCAAG 3′). Construction of the pHIL-S1 ex-
pression vector encoding hPGHS-2 has been described
elsewhere (Kukk et al. 2012). The heterologous expression
and protein purification were carried out as described pre-
viously (Kukk et al. 2012). Briefly, methanol induction was
carried out at 20°C for 72 hours, the yeast cells were dis-
rupted by sonication and the detergent-solubilised hPGHSs
were purified using Ni-affinity chromatography.
SDS-PAGE and Western blot analysis
Microsomes were prepared as reported previously (Kukk
et al. 2012). A 10% SDS-polyacrylamide gel with a 4%
stacking gel was used to separate the microsomal or
purified protein sample. The proteins were transferred
from the polyacrylamide gel onto the Protran BA85
nitrocellulose membrane (Whatman) using a Trans-Blot
Semi-Dry apparatus (Bio-Rad) and the Bjerrum and
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glycine, 1.3 mM SDS and 20% methanol). Mouse PGHS-1
specific (Life Technologies) or mouse PGHS-2 specific
monoclonal antibody (BD Biosciences) was used as the
primary antibody. Alkaline phosphatase conjugated goat
anti-mouse IgG (LabAs, Estonia) was used as the second-
ary antibody. The bands were visualized with nitro blue
tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate
(Sigma-Aldrich).
Detection of the hPGHS activity by incubation
with 14C-labeled arachidonic acid
The activity of hPGHSs was detected as described previ-
ously (Kukk et al. 2012). Briefly, the enzyme preparation
was incubated with 50 μM [1-14C] AA (500 cpm/μl) (GE
Healthcare) with intensive stirring for 10 min and the
products were extracted with ethyl acetate and analysed
by thin layer chromatography using authentic reference
standards of prostaglandins D2, E2 and F2α. A Wallac 1410
Liquid scintillation counter was used to count the 14C label
in stains. The extent of conversion of AA into prostaglan-
dins was calculated and expressed as the hPGHS activity in
picomoles of prostaglandins formed in 10 min per 1 mg
(wet weight) of yeast cells.
In-gel digestion and deglycosylation of hPGHSs
The purified protein sample was separated in 7% SDS-
polyacrylamide gel. The gel was stained with Coomassie
Brilliant Blue R-250 and destained with 40% methanol
and 10% acetic acid (AcOH). The region containing the
protein of interest (0.5-1 μg) was cut from the gel and
sliced into approximately 1 mm3 pieces. In-gel digestion
and subsequent deglycosylation were carried out using a
slightly modified method described by Hao et al. (2011).
Briefly, the gel samples were destained by vortexing in
1:1 acetonitrile (ACN): 50 mM ammonium acetate (AmAc),
pH 6 for 30 min. Then, the samples were reduced with
10 mM dithiothreitol at 56°C and alkylated with 50 mM
iodoacetamide for 20 min in the dark. The gel pieces were
dehydrated with ACN and dried under a hood. In-gel diges-
tion was carried out for 2 h on ice and then overnight at
37°C with 50 μl of 10 ng/μl proteomics grade trypsin
(Sigma), or a cocktail of sequencing grade Asp-N (Pro-
mega), Glu-C (Promega) and trypsin in 100 mM am-
monium bicarbonate buffer, pH 7.8. Peptides were extracted
from the gel by sonication for 5 min, followed by vortexing
in 2 volumes of 1:2 5% formic acid (FA): ACN for 30 min.
The solution was dried in a vacuum-centrifuge and the pep-
tides were reconstituted to 40 μl with 200 mM AmAc, pH 5
buffer in 98% H2
18O (Sigma). Then, 1 μl of PNGase F (New
England Biolabs) was added and the deglycosylation mix was
incubated at 37°C for 12 h. Finally, the peptides were purified
on C18 StageTip (Rappsilber et al. 2003) and reconstituted
with 0.5% trifluoroacetic acid.Nano-LC/MS/MS analysis of deglycosylated hPGHS
peptides
Peptides were separated on an Agilent 1200 series nano-
LC with in-house packed (3 μm ReproSil-Pur C18AQ
particles) 15 cm × 75 μm ID emitter-columns (New
Objective) using an 8-50% gradient of buffer B for 1 h,
whereas buffer A was 0.5% AcOH in water and B 0.5%
AcOH in 80% ACN. Separated peptides were eluted at
200 nl/min (spray voltage 2.0-2.2 kV) to a LTQ Orbi-
trap XL (Thermo Fisher Scientific) mass-spectrometer
operating with a top-5 MS/MS strategy with a mini-
mum of 1 s cycle time. The maximum ion injection
times were 500 ms, the dynamic exclusion was set to
60 s and only charge states over +1 were analysed. Al-
ternatively, the peptides were separated on an UltiMate
3000 RSLCnano (Dionex) using a cartridge trap-column
in backflush configuration and an analytical 50 cm Easy-
spray column (75 μm ID, 2 μm C18 particles) operated at
40°C and 1.8-2.1 kV. Peptides were eluted at 200 nl/min
using the previously mentioned gradient (except that 0.1%
FA was used instead of AcOH) to a Q Exactive MS/MS
(Thermo Fisher Scientific) operating with a top-10 strat-
egy with a maximum cycle time of 1 s (dynamic exclusion
set to 20 s).
Mass-spectrometric data analysis
Raw data were processed with the MaxQuant 1.4.0.8 soft-
ware package (Cox and Mann 2008). Spectra were searched
against UniProt (http://www.uniprot.org) P. pastoris
complete proteome database (2013 September) supple-
mented with PGHS sequences and common contaminants.
Missed cleavages were set to 2 and only identifications with
a minimum of 2 peptides 6 amino acids long were ac-
cepted. The protein and peptide false discovery rate was
set below 1%. Methionine oxidation, asparagine and glu-
tamine deamidation (with and without 18O) were set as
variable modifications. Carbamidomethylated cysteines
were set as fixed modifications. It was noted that in
some samples C-terminal oxygens were also extensively
replaced with 18O, indicating residual trypsin activity in the
deglycosylation mix. For those cases, analysis was redone
using C-terminal 18O double substitution as an additional
fixed modification. All other parameters were default.
Additional file
Additional file 1: Table S1. Complete list of the identified peptides of
PGHS proteins.
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